Paliperidon (Indonesian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Paliperidon" in Indonesian language version.

Last modified: 17:51:51, 13 June 2026 (UTC)

Ref.Un. Ref.Website

Global rank Indonesian rank

3625web.archive.org

1^st place

2716nih.gov

5^th place

6^th place

149europa.eu

62^nd place

116^th place

128doi.org

2^nd place

63semanticscholar.org

15^th place

26^th place

21archive.org

6^th place

3^rd place

11canada.ca

1,114^th place

2,414^th place

11hdl.handle.net

66^th place

122^nd place

11books.google.com

3^rd place

4^th place

11drugbank.ca

5,595^th place

3,768^th place

11escholarship.org

1,477^th place

1,157^th place

11japantimes.co.jp

407^th place

243^rd place

11lapresse.ca

935^th place

7,887^th place

1120min.ch

2,798^th place

6,398^th place

11nzherald.co.nz

390^th place

876^th place

11japantoday.com

4,588^th place

1,861^st place

11madinamerica.com

low place

11skynews.com.au

6,926^th place

7,363^rd place

11fda.gov

470^th place

343^rd place

20min.ch (Global: 2,798^th place; Indonesian: 6,398^th place)

"20 minutes - Un médicament anti-schizophrénie tue". Monde. April 9, 2014. Diarsipkan dari versi aslinya tanggal April 23, 2014. Diakses tanggal April 21, 2014.

archive.org (Global: 6^th place; Indonesian: 3^rd place)

Leucht S, Cipriani A, Spineli L, Mavridis D, Orey D, Richter F, Samara M, Barbui C, Engel RR, Geddes JR, Kissling W, Stapf MP, Lässig B, Salanti G, Davis JM (September 2013). "Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis". Lancet. 382 (9896): 951–962. doi:10.1016/S0140-6736(13)60733-3. PMID 23810019. S2CID 32085212.

books.google.com (Global: 3^rd place; Indonesian: 4^th place)

Haddad PM, Dursun S, Deakin B (2004). Adverse Syndromes and Psychiatric Drugs: A Clinical Guide. OUP Oxford. hlm. 207–216. ISBN 9780198527480. Diarsipkan dari versi aslinya tanggal January 10, 2023. Diakses tanggal August 28, 2020.

canada.ca (Global: 1,114^th place; Indonesian: 2,414^th place)

"Product monograph brand safety updates". Health Canada. July 7, 2016. Diarsipkan dari versi aslinya tanggal March 29, 2024. Diakses tanggal April 3, 2024.

doi.org (Global: 2^nd place; Indonesian: 2^nd place)

Chue P, Chue J (December 2012). "A review of paliperidone palmitate". Expert Review of Neurotherapeutics. 12 (12): 1383–1397. doi:10.1586/ern.12.137. PMID 23237346. S2CID 36437470.
Leucht S, Cipriani A, Spineli L, Mavridis D, Orey D, Richter F, Samara M, Barbui C, Engel RR, Geddes JR, Kissling W, Stapf MP, Lässig B, Salanti G, Davis JM (September 2013). "Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis". Lancet. 382 (9896): 951–962. doi:10.1016/S0140-6736(13)60733-3. PMID 23810019. S2CID 32085212.
Edinoff AN, Doppalapudi PK, Orellana C, Ochoa C, Patti S, Ghaffar Y, Cornett EM, Kaye AJ, Viswanath O, Urits I, Kaye AM, Kaye AD (2021). "Paliperidone 3-Month Injection for Treatment of Schizophrenia: A Narrative Review". Frontiers in Psychiatry. 12: 699748. doi:10.3389/fpsyt.2021.699748. PMC 8490677. PMID 34621193.{{cite journal}}: Pemeliharaan CS1: nomor artikel sebagai nomor halaman (link)
Allott K, Yuen HP, Baldwin L, O'Donoghue B, Fornito A, Chopra S, Nelson B, Graham J, Kerr MJ, Proffitt TM, Ratheesh A, Alvarez-Jimenez M, Harrigan S, Brown E, Thompson AD, Pantelis C, Berk M, McGorry PD, Francey SM, Wood SJ (June 2023). "Effects of risperidone/paliperidone versus placebo on cognitive functioning over the first 6 months of treatment for psychotic disorder: secondary analysis of a triple-blind randomised clinical trial". Translational Psychiatry. 13 (1): 199. doi:10.1038/s41398-023-02501-7. PMC 10257667. PMID 37301832.
Corena-McLeod M (June 2015). "Comparative Pharmacology of Risperidone and Paliperidone". Drugs in R&D. 15 (2): 163–174. doi:10.1007/s40268-015-0092-x. PMC 4488186. PMID 25943458.
Wang JS, Ruan Y, Taylor RM, Donovan JL, Markowitz JS, DeVane CL (December 2004). "The brain entry of risperidone and 9-hydroxyrisperidone is greatly limited by P-glycoprotein". The International Journal of Neuropsychopharmacology. 7 (4): 415–419. doi:10.1017/S1461145704004390. PMID 15683552.
Gurley BJ, Swain A, Williams DK, Barone G, Battu SK (July 2008). "Gauging the clinical significance of P-glycoprotein-mediated herb-drug interactions: comparative effects of St. John's wort, Echinacea, clarithromycin, and rifampin on digoxin pharmacokinetics". Molecular Nutrition & Food Research. 52 (7): 772–779. doi:10.1002/mnfr.200700081. PMC 2562898. PMID 18214850.
Gray JA, Roth BL (October 2007). "The pipeline and future of drug development in schizophrenia". Molecular Psychiatry. 12 (10): 904–922. doi:10.1038/sj.mp.4002062. PMID 17667958. S2CID 1672835. Diarsipkan dari versi aslinya tanggal January 23, 2023. Diakses tanggal November 26, 2022.

drugbank.ca (Global: 5,595^th place; Indonesian: 3,768^th place)

"Paliperidone". DrugBank. Diarsipkan dari versi aslinya tanggal November 17, 2011. Diakses tanggal November 18, 2011.

escholarship.org (Global: 1,477^th place; Indonesian: 1,157^th place)

Gray JA, Roth BL (October 2007). "The pipeline and future of drug development in schizophrenia". Molecular Psychiatry. 12 (10): 904–922. doi:10.1038/sj.mp.4002062. PMID 17667958. S2CID 1672835. Diarsipkan dari versi aslinya tanggal January 23, 2023. Diakses tanggal November 26, 2022.

europa.eu (Global: 62^nd place; Indonesian: 116^th place)

ema.europa.eu

"Invega EPAR". European Medicines Agency. June 25, 2007. Diarsipkan dari versi aslinya tanggal January 9, 2021. Diakses tanggal February 1, 2024. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
"Byannli EPAR". European Medicines Agency. April 28, 2020. Diarsipkan dari versi aslinya tanggal March 5, 2023. Diakses tanggal March 4, 2023.
"Trevicta EPAR". European Medicines Agency. December 5, 2014. Diarsipkan dari versi aslinya tanggal February 1, 2024. Diakses tanggal February 1, 2024.
"Xeplion EPAR". European Medicines Agency. March 4, 2011. Diarsipkan dari versi aslinya tanggal February 17, 2024. Diakses tanggal February 1, 2024.
"Niapelf EPAR". European Medicines Agency (EMA). March 21, 2024. Diarsipkan dari versi aslinya tanggal February 17, 2024. Diakses tanggal April 5, 2024.
"Procedural steps taken and scientific information after the authorisation" (PDF). EMA. July 16, 2015. Diarsipkan dari asli (PDF) tanggal June 18, 2018. Diakses tanggal May 8, 2017.
"Paliperidone extended release: Scientific Discussion" (PDF). EMA. July 16, 2007. Diarsipkan dari asli (PDF) tanggal May 19, 2012. Diakses tanggal May 8, 2017.
"Trevicta (previously Paliperidone Janssen)". Summary of the European public assessment report (EPAR) for Trevicta. EMC. September 17, 2018. Diarsipkan dari asli tanggal June 20, 2018. Diakses tanggal January 17, 2017.

ec.europa.eu

"Byannli Product information". Union Register of medicinal products. Diarsipkan dari versi aslinya tanggal March 5, 2023. Diakses tanggal March 3, 2023.

fda.gov (Global: 470^th place; Indonesian: 343^rd place)

accessdata.fda.gov

"Invega Trinza (paliperidone palmitate) NDA approval letter" (PDF). U.S. Food and Drug Administration. Diarsipkan dari asli (PDF) tanggal December 22, 2015. Diakses tanggal December 10, 2015.

hdl.handle.net (Global: 66^th place; Indonesian: 122^nd place)

World Health Organization (2023). The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023). Geneva: World Health Organization. hdl:10665/371090. WHO/MHP/HPS/EML/2023.02.

japantimes.co.jp (Global: 407^th place; Indonesian: 243^rd place)

"21 users of schizophrenia drug dead". The Japan Times Online. The Japan Times. April 18, 2014. Diarsipkan dari versi aslinya tanggal July 3, 2021. Diakses tanggal April 21, 2014.

japantoday.com (Global: 4,588^th place; Indonesian: 1,861^st place)

"17 deaths reported after schizophrenia drug injections". Japan Today: Japan News and Discussion. April 10, 2014. Diarsipkan dari versi aslinya tanggal April 23, 2014. Diakses tanggal April 21, 2014.

lapresse.ca (Global: 935^th place; Indonesian: 7,887^th place)

"Schizophrénie: controverse autour d'un médicament au Japon". Médecine. April 9, 2014. Diarsipkan dari versi aslinya tanggal April 22, 2014. Diakses tanggal April 21, 2014.

madinamerica.com (Global: low place; Indonesian: low place)

"21 Dead in Japan From New Johnson & Johnson Antipsychotic". Mad In America. April 18, 2014. Diarsipkan dari versi aslinya tanggal April 22, 2014. Diakses tanggal April 21, 2014.

nih.gov (Global: 5^th place; Indonesian: 6^th place)

pubmed.ncbi.nlm.nih.gov

Chue P, Chue J (December 2012). "A review of paliperidone palmitate". Expert Review of Neurotherapeutics. 12 (12): 1383–1397. doi:10.1586/ern.12.137. PMID 23237346. S2CID 36437470.
Leucht S, Cipriani A, Spineli L, Mavridis D, Orey D, Richter F, Samara M, Barbui C, Engel RR, Geddes JR, Kissling W, Stapf MP, Lässig B, Salanti G, Davis JM (September 2013). "Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis". Lancet. 382 (9896): 951–962. doi:10.1016/S0140-6736(13)60733-3. PMID 23810019. S2CID 32085212.
Edinoff AN, Doppalapudi PK, Orellana C, Ochoa C, Patti S, Ghaffar Y, Cornett EM, Kaye AJ, Viswanath O, Urits I, Kaye AM, Kaye AD (2021). "Paliperidone 3-Month Injection for Treatment of Schizophrenia: A Narrative Review". Frontiers in Psychiatry. 12: 699748. doi:10.3389/fpsyt.2021.699748. PMC 8490677. PMID 34621193.{{cite journal}}: Pemeliharaan CS1: nomor artikel sebagai nomor halaman (link)
Allott K, Yuen HP, Baldwin L, O'Donoghue B, Fornito A, Chopra S, Nelson B, Graham J, Kerr MJ, Proffitt TM, Ratheesh A, Alvarez-Jimenez M, Harrigan S, Brown E, Thompson AD, Pantelis C, Berk M, McGorry PD, Francey SM, Wood SJ (June 2023). "Effects of risperidone/paliperidone versus placebo on cognitive functioning over the first 6 months of treatment for psychotic disorder: secondary analysis of a triple-blind randomised clinical trial". Translational Psychiatry. 13 (1): 199. doi:10.1038/s41398-023-02501-7. PMC 10257667. PMID 37301832.
Corena-McLeod M (June 2015). "Comparative Pharmacology of Risperidone and Paliperidone". Drugs in R&D. 15 (2): 163–174. doi:10.1007/s40268-015-0092-x. PMC 4488186. PMID 25943458.
Wang JS, Ruan Y, Taylor RM, Donovan JL, Markowitz JS, DeVane CL (December 2004). "The brain entry of risperidone and 9-hydroxyrisperidone is greatly limited by P-glycoprotein". The International Journal of Neuropsychopharmacology. 7 (4): 415–419. doi:10.1017/S1461145704004390. PMID 15683552.
Gurley BJ, Swain A, Williams DK, Barone G, Battu SK (July 2008). "Gauging the clinical significance of P-glycoprotein-mediated herb-drug interactions: comparative effects of St. John's wort, Echinacea, clarithromycin, and rifampin on digoxin pharmacokinetics". Molecular Nutrition & Food Research. 52 (7): 772–779. doi:10.1002/mnfr.200700081. PMC 2562898. PMID 18214850.
Gray JA, Roth BL (October 2007). "The pipeline and future of drug development in schizophrenia". Molecular Psychiatry. 12 (10): 904–922. doi:10.1038/sj.mp.4002062. PMID 17667958. S2CID 1672835. Diarsipkan dari versi aslinya tanggal January 23, 2023. Diakses tanggal November 26, 2022.

dailymed.nlm.nih.gov

"Invega- paliperidone tablet, extended release". DailyMed. Diarsipkan dari versi aslinya tanggal January 24, 2016. Diakses tanggal August 19, 2020.
"Invega Hafyera- paliperidone palmitate injection, suspension, extended release". DailyMed. Diarsipkan dari versi aslinya tanggal October 20, 2021. Diakses tanggal October 31, 2021.
"Invega Sustenna- paliperidone palmitate injection". DailyMed. January 31, 2019. Diarsipkan dari versi aslinya tanggal May 13, 2021. Diakses tanggal August 19, 2020.
"Invega Trinza- paliperidone palmitate injection, suspension, extended release". DailyMed. January 31, 2019. Diarsipkan dari versi aslinya tanggal June 17, 2021. Diakses tanggal August 19, 2020.

ncbi.nlm.nih.gov

Edinoff AN, Doppalapudi PK, Orellana C, Ochoa C, Patti S, Ghaffar Y, Cornett EM, Kaye AJ, Viswanath O, Urits I, Kaye AM, Kaye AD (2021). "Paliperidone 3-Month Injection for Treatment of Schizophrenia: A Narrative Review". Frontiers in Psychiatry. 12: 699748. doi:10.3389/fpsyt.2021.699748. PMC 8490677. PMID 34621193.{{cite journal}}: Pemeliharaan CS1: nomor artikel sebagai nomor halaman (link)
Allott K, Yuen HP, Baldwin L, O'Donoghue B, Fornito A, Chopra S, Nelson B, Graham J, Kerr MJ, Proffitt TM, Ratheesh A, Alvarez-Jimenez M, Harrigan S, Brown E, Thompson AD, Pantelis C, Berk M, McGorry PD, Francey SM, Wood SJ (June 2023). "Effects of risperidone/paliperidone versus placebo on cognitive functioning over the first 6 months of treatment for psychotic disorder: secondary analysis of a triple-blind randomised clinical trial". Translational Psychiatry. 13 (1): 199. doi:10.1038/s41398-023-02501-7. PMC 10257667. PMID 37301832.
Corena-McLeod M (June 2015). "Comparative Pharmacology of Risperidone and Paliperidone". Drugs in R&D. 15 (2): 163–174. doi:10.1007/s40268-015-0092-x. PMC 4488186. PMID 25943458.
Gurley BJ, Swain A, Williams DK, Barone G, Battu SK (July 2008). "Gauging the clinical significance of P-glycoprotein-mediated herb-drug interactions: comparative effects of St. John's wort, Echinacea, clarithromycin, and rifampin on digoxin pharmacokinetics". Molecular Nutrition & Food Research. 52 (7): 772–779. doi:10.1002/mnfr.200700081. PMC 2562898. PMID 18214850.

nzherald.co.nz (Global: 390^th place; Indonesian: 876^th place)

"Deaths reported after Xeplion injections". Life & Style. NZ Herald News. Diarsipkan dari asli tanggal March 4, 2016. Diakses tanggal April 21, 2014.

semanticscholar.org (Global: 15^th place; Indonesian: 26^th place)

api.semanticscholar.org

Chue P, Chue J (December 2012). "A review of paliperidone palmitate". Expert Review of Neurotherapeutics. 12 (12): 1383–1397. doi:10.1586/ern.12.137. PMID 23237346. S2CID 36437470.
Leucht S, Cipriani A, Spineli L, Mavridis D, Orey D, Richter F, Samara M, Barbui C, Engel RR, Geddes JR, Kissling W, Stapf MP, Lässig B, Salanti G, Davis JM (September 2013). "Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis". Lancet. 382 (9896): 951–962. doi:10.1016/S0140-6736(13)60733-3. PMID 23810019. S2CID 32085212.
Gray JA, Roth BL (October 2007). "The pipeline and future of drug development in schizophrenia". Molecular Psychiatry. 12 (10): 904–922. doi:10.1038/sj.mp.4002062. PMID 17667958. S2CID 1672835. Diarsipkan dari versi aslinya tanggal January 23, 2023. Diakses tanggal November 26, 2022.

skynews.com.au (Global: 6,926^th place; Indonesian: 7,363^rd place)

"Schizophrenia drug blamed for 17 deaths". Sky News Australia. June 29, 2023. Diarsipkan dari versi aslinya tanggal April 13, 2014. Diakses tanggal April 21, 2014.

web.archive.org (Global: 1^st place; Indonesian: 1^st place)

"Product monograph brand safety updates". Health Canada. July 7, 2016. Diarsipkan dari versi aslinya tanggal March 29, 2024. Diakses tanggal April 3, 2024.
"Invega- paliperidone tablet, extended release". DailyMed. Diarsipkan dari versi aslinya tanggal January 24, 2016. Diakses tanggal August 19, 2020.
"Invega Hafyera- paliperidone palmitate injection, suspension, extended release". DailyMed. Diarsipkan dari versi aslinya tanggal October 20, 2021. Diakses tanggal October 31, 2021.
"Invega Sustenna- paliperidone palmitate injection". DailyMed. January 31, 2019. Diarsipkan dari versi aslinya tanggal May 13, 2021. Diakses tanggal August 19, 2020.
"Invega Trinza- paliperidone palmitate injection, suspension, extended release". DailyMed. January 31, 2019. Diarsipkan dari versi aslinya tanggal June 17, 2021. Diakses tanggal August 19, 2020.
"Invega EPAR". European Medicines Agency. June 25, 2007. Diarsipkan dari versi aslinya tanggal January 9, 2021. Diakses tanggal February 1, 2024. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
"Byannli EPAR". European Medicines Agency. April 28, 2020. Diarsipkan dari versi aslinya tanggal March 5, 2023. Diakses tanggal March 4, 2023.
"Byannli Product information". Union Register of medicinal products. Diarsipkan dari versi aslinya tanggal March 5, 2023. Diakses tanggal March 3, 2023.
"Trevicta EPAR". European Medicines Agency. December 5, 2014. Diarsipkan dari versi aslinya tanggal February 1, 2024. Diakses tanggal February 1, 2024.
"Xeplion EPAR". European Medicines Agency. March 4, 2011. Diarsipkan dari versi aslinya tanggal February 17, 2024. Diakses tanggal February 1, 2024.
"Niapelf EPAR". European Medicines Agency (EMA). March 21, 2024. Diarsipkan dari versi aslinya tanggal February 17, 2024. Diakses tanggal April 5, 2024.
"Procedural steps taken and scientific information after the authorisation" (PDF). EMA. July 16, 2015. Diarsipkan dari asli (PDF) tanggal June 18, 2018. Diakses tanggal May 8, 2017.
Haddad PM, Dursun S, Deakin B (2004). Adverse Syndromes and Psychiatric Drugs: A Clinical Guide. OUP Oxford. hlm. 207–216. ISBN 9780198527480. Diarsipkan dari versi aslinya tanggal January 10, 2023. Diakses tanggal August 28, 2020.
"Paliperidone". DrugBank. Diarsipkan dari versi aslinya tanggal November 17, 2011. Diakses tanggal November 18, 2011.
"Paliperidone extended release: Scientific Discussion" (PDF). EMA. July 16, 2007. Diarsipkan dari asli (PDF) tanggal May 19, 2012. Diakses tanggal May 8, 2017.
Gray JA, Roth BL (October 2007). "The pipeline and future of drug development in schizophrenia". Molecular Psychiatry. 12 (10): 904–922. doi:10.1038/sj.mp.4002062. PMID 17667958. S2CID 1672835. Diarsipkan dari versi aslinya tanggal January 23, 2023. Diakses tanggal November 26, 2022.
"21 users of schizophrenia drug dead". The Japan Times Online. The Japan Times. April 18, 2014. Diarsipkan dari versi aslinya tanggal July 3, 2021. Diakses tanggal April 21, 2014.
"Schizophrénie: controverse autour d'un médicament au Japon". Médecine. April 9, 2014. Diarsipkan dari versi aslinya tanggal April 22, 2014. Diakses tanggal April 21, 2014.
"20 minutes - Un médicament anti-schizophrénie tue". Monde. April 9, 2014. Diarsipkan dari versi aslinya tanggal April 23, 2014. Diakses tanggal April 21, 2014.
"Deaths reported after Xeplion injections". Life & Style. NZ Herald News. Diarsipkan dari asli tanggal March 4, 2016. Diakses tanggal April 21, 2014.
"17 deaths reported after schizophrenia drug injections". Japan Today: Japan News and Discussion. April 10, 2014. Diarsipkan dari versi aslinya tanggal April 23, 2014. Diakses tanggal April 21, 2014.
"21 Dead in Japan From New Johnson & Johnson Antipsychotic". Mad In America. April 18, 2014. Diarsipkan dari versi aslinya tanggal April 22, 2014. Diakses tanggal April 21, 2014.
"Schizophrenia drug blamed for 17 deaths". Sky News Australia. June 29, 2023. Diarsipkan dari versi aslinya tanggal April 13, 2014. Diakses tanggal April 21, 2014.
"Invega Trinza (paliperidone palmitate) NDA approval letter" (PDF). U.S. Food and Drug Administration. Diarsipkan dari asli (PDF) tanggal December 22, 2015. Diakses tanggal December 10, 2015.
"Trevicta (previously Paliperidone Janssen)". Summary of the European public assessment report (EPAR) for Trevicta. EMC. September 17, 2018. Diarsipkan dari asli tanggal June 20, 2018. Diakses tanggal January 17, 2017.

Paliperidon (Indonesian Wikipedia)

20min.ch (Global: 2,798th place; Indonesian: 6,398th place)

archive.org (Global: 6th place; Indonesian: 3rd place)

books.google.com (Global: 3rd place; Indonesian: 4th place)

canada.ca (Global: 1,114th place; Indonesian: 2,414th place)

doi.org (Global: 2nd place; Indonesian: 2nd place)

drugbank.ca (Global: 5,595th place; Indonesian: 3,768th place)

escholarship.org (Global: 1,477th place; Indonesian: 1,157th place)

europa.eu (Global: 62nd place; Indonesian: 116th place)